IAIM
RIGL icon

International Assets Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

International Assets Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268 Hold
7
– – ﹤0.01% 2299
2026
Q1 		$193 Hold
7
– – ﹤0.01% 2197
2025
Q4 		$300 Buy
+7
New +$264 ﹤0.01% 2139
2024
Q4 		– Sell
-7
Closed -$113 – 1665
2024
Q3 		$113 Hold
7
– – ﹤0.01% 1804
2024
Q2 		$58 Buy
+7
New +$73 ﹤0.01% 2249
2023
Q2 		– Sell
-7
Closed -$94 – 819
2023
Q1 		$94 Buy
+7
New +$111 ﹤0.01% 1121

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

International Assets Investment Management's RIGL Position: Q2 2026 in Review

International Assets Investment Management held its Rigel Pharmaceuticals (RIGL) position steady in Q2 2026 at 7 shares worth $268. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

International Assets Investment Management first reported a position in RIGL in Q1 2023 and has held it in 6 quarters since. The position peaked at $300 in Q4 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • International Assets Investment Management held 7 shares of Rigel Pharmaceuticals worth $268 as of Q2 2026.
  • International Assets Investment Management left its Rigel Pharmaceuticals share count unchanged in Q2 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2299 holding.
  • International Assets Investment Management first reported a position in Rigel Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • International Assets Investment Management's Rigel Pharmaceuticals position peaked at $300 in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.